LPL Financial LLC Invests $244,000 in Grail, Inc. (NASDAQ:GRAL)

LPL Financial LLC purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 13,669 shares of the company's stock, valued at approximately $244,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Crcm LP purchased a new position in shares of Grail during the 4th quarter worth $65,061,000. Primecap Management Co. CA purchased a new position in Grail during the fourth quarter valued at $37,118,000. Bank of New York Mellon Corp purchased a new stake in Grail in the fourth quarter worth about $6,262,000. TCW Group Inc. bought a new position in shares of Grail in the fourth quarter worth about $5,095,000. Finally, abrdn plc purchased a new position in shares of Grail during the 4th quarter valued at about $3,768,000.

Insider Buying and Selling at Grail

In related news, CEO Robert P. Ragusa sold 7,625 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.21, for a total transaction of $237,976.25. Following the completion of the sale, the chief executive officer now owns 828,662 shares of the company's stock, valued at $25,862,541.02. This represents a 0.91 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the transaction, the president now directly owns 559,673 shares in the company, valued at $17,461,797.60. This represents a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 11,550 shares of company stock valued at $360,436.

Grail Stock Performance

Shares of Grail stock traded down $2.00 during trading hours on Thursday, reaching $32.49. The company's stock had a trading volume of 1,319,393 shares, compared to its average volume of 1,224,471. The firm has a 50 day moving average price of $30.48 and a 200-day moving average price of $24.73. Grail, Inc. has a one year low of $12.33 and a one year high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts' consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. On average, equities research analysts forecast that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Canaccord Genuity Group started coverage on shares of Grail in a research note on Monday, April 21st. They set a "buy" rating and a $32.00 target price on the stock. Morgan Stanley lifted their target price on shares of Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.